LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice
Park, Jong-Gil, Jeong, Se-Jin, Yu, Jinha, Kim, Gyudong, Jeong, Lak Shin, Oh, Goo TaegVolume:
51
Journal:
BMB Reports
DOI:
10.5483/BMBRep.2018.51.10.098
Date:
October, 2018
File:
PDF, 599 KB
2018